To delineate the scope of the human intraovarian IL-1 system we used a solution hybridization/RNase protection assay to test for expression of the genes encoding IL-1, its type I receptor (IL-iR), and its receptor antagonist (IL-iRA). IL-1 transcripts were not detected in whole ovarian material from days 4 or 12 of an unstimulated menstrual cycle but transcripts (IL-i10 >> IL-lla) were detected in preovulatory follicular aspirates from gonadotropin-stimulated cycles. Concurrently obtained peripheral monocytes did not contain IL-1,6 transcripts but macrophage-depleted follicular aspirates did, thus implicating the granulosa cells as the site of IL-1 expression. IL-iR transcripts were detected in RNA from whole ovaries and follicular aspirates but not in RNA from peripheral monocytes. IL-iRA transcripts were detected in whole ovarian material as well as in macrophage-free follicular aspirates. Cultured human granulosa and theca cells did not contain mRNA for IL-1,B or IL-iRA but did contain mRNA for IL-1R. Treatment of cell cultures with forskolin (25 ,uM) induced IL-i#t transcripts in granulosa but not theca cells. Forskolin also increased the basal levels of IL-iR transcripts in both granulosa and theca cells but did not induce IL-RA transcripts in either cell type. Taken together, these findings reveal the existence of a complete, highly compartmentalized, hormonally dependent intraovarian IL-1 system replete with ligands, receptor, and receptor antagonist. (J.
Introduction
Interleukin-1, a prominent 17-kD member of a group of immune mediators referred to as cytokines (1) (2) (3) (4) , is secreted by a variety of immuno-and nonimmunocompetent cells (5) . Although the relevance of IL-1 to ovarian physiology remains uncertain, several lines of evidence support such possibility.
First, significant amounts of IL-l-like activity have been de-tected in both porcine (6) and human (7) follicular fluid. Second, in vitro studies at the level of the murine and porcine ovary revealed IL-I to possess potent antigonadotropic (8) (9) (10) (11) (12) (13) (14) (15) (16) or steroidogenic (17) properties contingent upon the experimental circumstances under study. Accordingly, it is tempting to speculate that locally derived IL-1, possibly originating from somatic ovarian cells or resident ovarian macrophages, may be the centerpiece ofan intraovarian regulatory loop. Since IL-1 is an established mediator of inflammation (18) and since ovulation may constitute an inflammatory-like reaction (19, 20) , consideration may be given to the possibility that IL-l may play an intermediary role in the ovulatory process. Such speculation is further supported by the recognition that IL-l has been shown in multiple nonovarian tissues to promote several ovulation-associated phenomena such as prostaglandin biosynthesis (21) , plasminogen activator production (22) , glycosaminoglycan generation (23) , vascular permeability enhancement (24) , and collagenase activation (21) .
To begin to evaluate the above hypothesis, we have undertaken to explore the possibility that the genes encoding IL-1, its receptor, and its receptor antagonist are expressed at the level of the human ovary. Moreover, we have set out to determine the cellular localization and gonadotropic regulation of the various components of the human intraovarian IL-1 system.
Methods

Reagents and hormones
McCoy's 5a medium (modified, without serum), penicillin-streptomycin solution (100 mg/ml), L-glutamine (29.2 mg/ml), trypan blue stain (0.4%, wt/vol), and fetal bovine serum (FBS) were obtained from Gibco Laboratories (Grand Island, NY) . Forskolin, (7#-acetoxy-8,13-eppoxy-la 6#, 9a-trihydroxy-labd-14-en-l 1-one) was Freshly derived tissues and cells Unstimulated day 4 and day 12 ovaries were obtained from normally cycling women undergoing total abdominal hysterectomy and bilateral salpingo-oophorectorny for nonovarian indications. Preovulatory follicular aspirates were secured at the time of oocyte retrieval from the ovaries of normal ovulatory women undergoing controlled gonadotropic ovarian hyperstimulation and ovulation for the purpose of in vitro fertilization (IVF)' and embryo transfer (ET). The aforementioned "flare up" gonadotropic ovarian hyperstimulation protocol involved 1. Abbreviations used in this paper: ET, embryo transfer; IL-IR, IL-I receptor; IL-I RA, IL-I receptor antagonist; IVF, in vitro fertilization; LSM, lymphocyte separation medium; RT, room temperature. the sequential application of a GnRH agonist (Lupron; Tap Pharmaceuticals, North Chicago, IL), human menopausal gonadotropins (Pergonal; Serono Laboratories, Randolph, MA), pure follicle stimulating hormone (Metrodin; Serono Laboratories, Inc., Randolph, MA), and human chorionic gonadotropin (Profasi; Serono Laboratories) as previously described (25) . Contaminating erythrocytes and debris present in blood-stained follicular aspirates were separated by a lymphocyte separation medium (LSM; Organon Teknika, Durham, NC) as previously described (26) . Peripheral monocytes, obtained from women undergoing IVF/ET at the time offollicular aspiration were similarly separated from other blood cell elements (26) . Term human placentae were obtained immediately after delivery. All tissue samples were obtained in keeping with protocols approved by the institutional review board of the corresponding institutions.
Tissue culture procedures Secondary granulosa cell cultures, established from preovulatory (IVFderived) follicular aspirates as previously described (27) , were grown for 48 h under serum-free conditions in the absence or presence of forskolin (25 MM) . Specifically, after removal of the oocyte from the follicular fluid, several samples of the latter were pooled and centrifuged at 1,000 g, and the thin layer ofgranulosa-luteal cells (located on top of the clotted blood pellet) isolated with a Pasteur pipette and suspended in culture medium containing 20% FBS and 10% DMSO. Vials containing the cells were immediately frozen using a liquid nitrogen cryostat. After freezing, the vials were plunged into liquid nitrogen and stored until required. Cells from different patients were not pooled. After thawing, cells were grown to confluence and removed from the dish with neutral protease after which time the secondary cells were frozen and stored as described above. Data presented in this report were obtained with cells thawed, grown, and passaged from stored secondary vials from various lots of primary cells. Secondary cultures of theca-interna cells were established as previously described (28) from follicle biopsies from preovulatory follicles ofwomen undergoing laparoscopy for gamete intrafallopian tube transfer or in vitro fertilization procedures. A suspension of thecal cells was obtained after dispersal with 0.05% collagenase 1, 0.05% collagenase IA, and 0.01% DNAse in a medium containing 20% FBS. Dispersed cells were frozen and stored in culture media containing 10% FBS and 20% DMSO in a liquid nitrogen cryostate until required for experiments. Subculture was performed by incubation with neutral protease (pronase-E; protease type XIV) in 10% FBS. The resultant cells were maintained as described for granulosa cells in the absence or presence of forskolin (25 MM). The epidermal carcinoma cell line A431 was grown to confluency in McCoy's 5a medium (modified, without serum), supplemented with a penicillin (100 ,g/ml) streptomycin (100 jg/ml) solution, L-glutamine (2 mM), and 10% FBS.
Immunohistochemical staining ofhuman macrophages
Secondary cell cultures ofgranulosa cells, obtained and maintained as described above, were grown on sterile chamber slides (Nunc, Inc., Naperville, IL) and stored desiccated at -20°C until used. The cells were then fixed onto the slide by incubation with acetone for 10 min at room temperature (RT) followed by rehydration in PBS for 10 min at RT. All subsequent steps (until the addition ofdiaminobenzidine) were carried out in a moist chamber at RT. Endogenous peroxidase was blocked by incubation in 0.3% H202 in PBS for 15 min at RT. Normal horse serum (Vectastain kit; Vector Laboratories, Inc., Burlingame, CA) was then applied to the slides for 20 min, the serum decanted, and the primary antibody (EBM-I 1, diluted 1:20 in PBS) added for 30 min, followed by a PBS rinse. The latter monoclonal antiserum (DakoMacrophage; Dakopatts, Copenhagen, Denmark) was raised in mice against the cell surface antigen CD68 of human macrophages. The secondary antibody (biotinylated horse anti-mouse) was applied for 30 min followed by a PBS rinse. The avidin-biotin-peroxidase complex was added for 30 min and washed with phosphate buffer (PB, 0.01 M, pH 7.4). A 0.01% diaminobenzidine solution (in PB) was then added to the slides for 10 mmn, followed by a water rinse. (26) . Briefly, 100,000-300,000 cells were suspended in -100 ,ul of B cell medium (1.75 g BSA in 250 ml PBS containing 0.01% sodium azide). 5 Ml of the primary antibody EBM-l 1 diluted 1:5 in B cell medium was added to each of two tubes for both sorted and unsorted samples. Control tubes received no primary antibody. As an additional control, anti-CD68 magnetic beads were added (as described above) to unsorted cells and incubated for 15 min at RT. Then, 5 Ml of anti-human Leu-M5 (CDlIc; Becton Dickinson) diluted 1:5 in B cell medium was added.
Cells were incubated 15 min at RT in the dark, then washed with 2 ml B cell medium and centrifuged (TJ-6; Beckman Instruments, Inc., Palo Alto, CA) at 1,200 rpm for 5 min. Supernatants were decanted and 5 Ml secondary antibody (goat anti-mouse fluorescein isothiocyanate conjugated; Accurate Chemical Scientific Corp., Westbury, NY) diluted 1:4 in B cell medium was added to all tubes. Cells were again incubated 15 min at RT in the dark, followed by washing with B cell medium as described above. Supernatants were decanted and 100 Ml 1% paraformaldehyde was added to each tube.
RNA extraction
Tissues and cells previously frozen in liquid nitrogen (or at -70°C) were homogenized in 4 M guanidinium isothiocyanate using a homogenizer (Polytron; Instruments Co., Brinkmann Westbury, NY), the total RNA was fractionated over a CsCl column (29) , ethanol precipitated, resuspended in sterile water, quantified by absorbance at 260 nm, and assessed for integrity by visual inspection after electrophoresis through ethidium bromide-stained 1.25%/2.2-M formaldehyde gels. Solution hybridization/RNase protection assay Solution hybridization/RNase protection assays were performed as previously described (32) . Briefly, riboprobes synthesized with T7 or SP6 RNA polymerase were labeled using [32P]UTP in accordance with the manufacturer's instructions (Promega Biotec). At the conclusion of transcription, 1 ng of DNase I (Cooper Biomedical Inc., Malvern, PA) was added, the mixture incubated for 15 min at 37°C, and the labeled riboprobe recovered by ethanol precipitation. 20 ug of total RNA was hybridized with 400,000 cpm of each 32P-labeled riboprobe for 16 h at 45°C in 75% formamide 0.4 M NaCI, followed by digestion with 40 gg/ml of RNase A and 2 ug/ml of RNase T 1. The resultant protected hybrids were isolated by ethanol precipitation and separated on an 8% polyacrylamide/8 M urea denaturing gel. The relative intensity ofprotected RNA bands was quantified by densitometric scanning.
Statistical analysis
Statistical significance was determined by Student's t test.
Results
To assess the possibility of ovarian IL-1 gene expression, 20 4g of total RNA was hybridized simultaneously with both the ILlCa and IL-lI3 riboprobes. No detectable IL-1 signal was evident in whole ovarian material from days 4 (04) or 12 (012) of an unstimulated menstrual cycle. However, as shown ( Fig. 1) , expected protected fragments corresponding to IL-la (670 bp) and IL-lIB (175 bp) transcripts were detected in preovulatory follicular aspirates (F) secured in the course of a stimulated IVF/ET cycle. IL-lI, transcripts proved significantly (P < 0.05) more abundant than their IL-la counterparts. Identical transcripts were noted in A431 keratinocytes (K), used herein as a positive control (33) . Note is made of the fact that IL-lI# transcripts were further represented by an additional, somewhat smaller protected fragment the exact origin(s) ofwhich remains uncertain. A similar doublet was apparent when using a distinct IL-lB-containing plasmid construct the transcription of which generated a 570-bp antisense riboprobe (not shown).
Given that the preovulatory follicular aspirates may constitute a complex mix of somatic ovarian and circulating cellular elements, we have undertaken to further identify the cell type responsible for IL-1 gene expression. In this connection, preovulatory peripheral monocytes (M) obtained at the time of oocyte retrieval proved negative (Fig. 1) (Fig. 2 A) revealing no more than 1-2% macrophage contamination of granulosa cell cultures as compared with the 10% figure reported for preovulatory follicular aspirates (26) . Given these cellular preparations, grown in the absence or presence of forskolin (25 ,M), a potent activator of adenylate cyclase, a faint protected fragment corresponding to IL-1B transcripts was detected in forskolin (Fo)-stimulated cultured granulosa (G) but not theca-interstitial (T) cells (Fig. 3) may be a site ofIL-1 ,3 gene expression. To address this issue in a more rigorous fashion, we have undertaken to generate macrophage-depleted follicular aspirates by way of magnetically driven immune sorting. To this end, use was made ofa human macrophage-directed antibody known to recognize the CD68 cell surface antigen. To validate the homogenous nature ofthe macrophage-free follicular aspirates, further immune sorting (using two distinct macrophage-directed antisera) was undertaken by way of flow cytometric analysis as previously described (26) . As shown (Fig. 4) , magnetically driven immune sorting of follicular aspirates yielded a homogenous granulosa cell population virtually devoid of macrophages. Given virtually macrophage-free follicular aspirates (Fig. 5) , IL-1I transcripts were detectable (G) indicating that the human granulosa cell is a site of IL-If# gene expression.
To explore the possibility of human ovarian IL-IR gene expression, 20 Atg of total RNA was hybridized with type I IL-IR riboprobe. As shown (Fig. 6) -+ g4 q2 F P M Figure 6 . Human ovarian type I IL-l receptor gene expression. A solution hybridization/RNase protection assay was performed using the IL-I receptor riboprobe as described in Methods. Total RNA (20 Ag) was extracted from tissues described in Fig. 1 IL-la and IL-1I3 are products of separate genes which, despite relatively limited (26% in the human) sequence homology, display similar biologic activities and interact with the same cell surface receptors (2). Our present findings reveal that preovulatory follicular aspirates are a site of both IL-la and IL-1I3 gene expression (Fig. 1) . However, IL-lI# proved far more abundant than IL-la ( Fig. 1) as previously shown for LPS-stimulated human monocytes (35) and epidermal keratinocytes (33) . In contrast, IL-1 transcripts were not evident in whole ovarian pendent. Although such conclusions may only be viewed as tentative at this time, the possibility of gonadotropin dependence is further supported by the documentation of IL-I B transcripts in forskolin-stimulated cultured granulosa cells (Fig. 2) . Accordingly, it is tempting to speculate that intraovarian IL-1, the acquisition ofwhich may be gonadotropin dependent, may play an intermediary role in the ovulatory cascade. Specifically, IL-I may be viewed as an extension of the gonadotropic signal, constituting one of several distal effectors the overall objective of which is the faithful execution of the gonadotropin-triggered preovulatory program. Further support for the above hypothesis can be derived from preliminary observations (not shown) wherein IL-I has been found to promote ovarial prostaglandin and proteoglycan biosynthesis. Although the precise cellular mechanism(s) by which gonadotropins may upregulate ovarian IL-I gene expression remain unknown, consideration must be given not only to the possibility of direct gonadotropic action but also to the possibility of indirect modulation via the intermediacy of ovarian steroids. This latter possibility is supported by earlier reports suggesting a role for steroids in the regulation of macrophage IL-I gene expression (36, 37) . Given the central role of cAMP in forskolin (or gonadotropin) hormonal action, it is possible that A-kinase activation may contribute to the upregulation of granulosa cell IL-I mRNA.
Given that preovulatory follicular aspirates may constitute a complex mix of somatic ovarian and circulating cellular elements (26), we have undertaken to further identify the cell type responsible for IL-I gene expression. In this connection, consideration was given to the possibility that contaminating peripheral monocytes contribute to the IL-I transcript pool detected in follicular aspirates. However, our present observations disclosed no IL-I transcripts in preovulatory peripheral monocytes obtained at the time ofoocyte retrieval (Fig. 1) . To further localize the cellular source ofthe ovarian IL-I message, use was also made of cultured human granulosa or theca-interstitial cells. This approach was predicted to yield macrophage-poor somatic ovarian cell preparations by virtue of limited macrophage proliferation potential (34) and multiple dilutional passages. Indeed, immunohistochemical studies (Fig. 2 A) revealed no more than 1-2% macrophage contamination of granulosa cell cultures as compared with the 10% figure reported for preovulatory follicular aspirates (26) . Given these macrophage-poor somatic ovarian cell cultures, we were in a position to document IL-1 # transcripts in forskolin-stimulated granulosa but not theca-interstitial cells suggesting IL-lI gene expression by a somatic ovarian cell type (Fig. 3) . That notwithstanding, the unexpected, albeit limited, presence of immunohistochemically detectable macrophages in repeatedly passaged cultured human granulosa cells could well prove quantitatively relevant to IL-1,8 gene expression. Thus, the preceding observations cannot be viewed as excluding possible contamination of preovulatory follicular aspirates by IL-l-producing resident ovarian macrophages. To address this issue in a more rigorous fashion, we have undertaken to generate virtually macrophage-free follicular aspirates by way of magnetically driven immune sorting. To this end, use was made ofa human macrophage-directed antibody known to recognize the CD68 cell surface antigen. The apparent purity ofthe cellular preparation was verified by flow cytometric analysis (Fig. 4) . Given such macrophage-depleted follicular aspirates, IL-1I# transcripts were detectable in macrophage-depleted follicular aspirates (G) indicating that the human granulosa cell is a site of IL-I1, gene expression (Fig. 5 ).
An increasing body of information is in keeping with the existence of two high affinity subtypes of the IL-1 receptor. Type I, an 80-kD protein, appears indigenous to T cells, fibroblasts, epithelial cells, and keratinocytes (38) (39) (40) . In contrast, the type II receptor, a 60-70-kD protein, resides primarily on B cells and macrophages (41) . Our present observations document type I IL-I receptor transcripts in whole ovaries from days 4 and 12 of an unstimulated menstrual cycle as well as in preovulatory follicular aspirates (Fig. 6) . Cellular localization studies displayed type I IL-I receptors transcripts in both granulosa and theca-interstitial cells the relative abundance of which proved subject to upregulation by forskolin (Fig. 7) . As such, these findings are in harmony with earlier observations revealing murine (8) (9) (10) (11) (12) and porcine (13) (14) (15) (16) somatic (granulosa and theca-interstitial) ovarian cells to be a site of IL-1 reception and action. Moreover, given the pivotal role ofgonadotropins in the promotion of follicular development (42) , the demonstration of forskolin-enhanced type I IL-l receptor transcripts strongly suggests that the acquisition ofIL-I responsiveness may be part and parcel ofgranulosa cell ontogeny. Accordingly, enhancement of IL-1 reception may be a mechanism whereby gonadotropins may condition the cell to respond optimally to IL- 1 Among autocrine/paracrine regulators, the IL-1 system stands out by virtue of the existence of a naturally occurring IL-1RA. The IL-1RA may well constitute the first naturally occurring receptor antagonist. Structurally similar both in sequence (30% homology) and size (17,000 kD) to IL1, the antagonist, unlike the agonistic ligand, is endowed with a signal peptide and thus may be in a position to access the exterior of the cell. In so doing, the IL-IRA may be in a position to provide temporally dependent virtually instantaneous regulation ofIL-1 hormonal action at the level ofcognate type I (but not type II) IL-I receptors (31, 44, 45) . Our present observations document IL-I RA transcripts in an unstimulated day 4 ovary as well as in native preovulatory follicular aspirates (Fig. 8) . A comparable signal was also evident in macrophage-free follicular aspirates thereby suggesting that the human granulosa cell is in fact a site of IL-IRA gene expression (Fig. 9) . In contrast, no detectable signal was noted in granulosa or theca-interstitial cells cultured in the absence or presence of forskolin (Fig. 8) . Although the precise reason(s) underlying the apparent absence of IL-IRA transcripts in secondary cultures of granulosa cells (as distinct from preovulatory follicular aspirates) remain unknown, the present findings establish the ability of the human ovary (and more specifically the granulosa cell) to engage in IL-I RA gene expression. The very ability of the ovary to express the IL-I receptor antagonist gene raises the prospect of its involvement in the regulation of IL-I hormonal action at the ovarian level. It is tempting to speculate that the seemingly constitutive expression ofIL-IRA may provide a tonic background ofantagonism to IL-I hormonal action. According to this view, net alterations in IL-I hormonal action may prove entirely dependent on the overall level of IL-I expression. Conceivably, it is this type of arrangement which may assure that IL-I is only active when required, activation being dependent on timely self-limited expression.
Taken together our findings reveal the presence of a complete intraovarian IL-i system replete with ligands, receptor, and a receptor antagonist. The apparent midcycle (presumably gonadotropin dependent) induction of IL-i gene expression and the ability of IL-l to promote a host of ovulation-associated phenomena (18) in nonovarian tissues, strongly suggests that IL-I may well play an intermediary role in the preovulatory cascade. The apparent gonadotropin dependence of the type I IL-I receptor is likewise compatible with that possibility. In vivo studies are currently underway to further test this hypothesis. The above notwithstanding, consideration must also be given to the possibility that IL-I may in fact play a role at times other than ovulation. Moreover, the very action of IL-I may be highly dependent on the stage of follicular development. In this connection note must be made of the generally antigonadotropic effect of IL-I as observed in differentiating granulosa (8) (9) (10) (11) (12) (13) (14) (15) (16) or theca-interstitial (46) cells. On the other hand, IL-I has been reported to increase the accumulation of both progesterone and estrogen in the context ofthe preovulatory hamster follicle (17) . Consequently, it is highly likely that the very action of IL-I is contingent upon the endocrine circumstances at play.
